‘Fluorescent markers’ to illuminate cancer begins Phase 3 clinical trials
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered…
Browsing: OTL38
First-of-its-kind technology lights up lung cancer cells, helps improve patient outcomes
A groundbreaking tumour-highlighting technology – OTL38 – enhances the visualisation of lung cancer tissue, providing…